Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Current Liabilities ₹365 Cr₹262 Cr₹216 Cr₹194 Cr₹98 Cr

What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹365 Cr
Mar2024₹262 Cr
Mar2023₹216 Cr
Mar2022₹194 Cr
Mar2013₹98 Cr

How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2025 ₹365 Cr
39.19
Mar2024 ₹262 Cr
21.26
Mar2023 ₹216 Cr
11.40
Mar2022 ₹194 Cr
98.02
Mar2013 ₹98 Cr -

Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹289.8 Cr -3.5% -5.7% -9.8% Stock Analytics
KAVERI SEED COMPANY ₹3,827.6 Cr -2.7% -3.5% -37.2% Stock Analytics
VENKYS (INDIA) ₹2,337.8 Cr -2.6% 6.2% 14.7% Stock Analytics
AVT NATURAL PRODUCTS ₹1,385.0 Cr -1% 27.2% 25.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹999.5 Cr 8% 6.5% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹469.6 Cr 0.1% -4.2% -7.9% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3.5%

-5.7%

-9.8%

SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses